You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent cervical cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Barretts Esophagus With Dysplasia Trial in Stockholm (ESD)

Recruiting
  • Barretts Esophagus With Dysplasia
  • ESD
  • Stockholm, Sweden
    Karolinska University Hospital
Aug 1, 2023

Locally Advanced Rectal Cancer Trial (AK104 injection, TME surgery, Capecitabine)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • AK104 injection
  • +3 more
  • (no location specified)
Apr 4, 2023

Breast Cancer, Sleep, Quality of Life Trial in Caen (Functional Magnetic Resonance Imaging at rest and in activation with

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Functional Magnetic Resonance Imaging at rest and in activation with attentional task
  • Caen, France
  • +1 more
Aug 9, 2022

HER2-positive Breast Cancer Trial (Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab))

Not yet recruiting
  • HER2-positive Breast Cancer
  • Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab)
  • (no location specified)
Jul 20, 2023

Colonoscopy, Colorectal Tumors, Intestinal Polyps Trial in Talence (screening colonoscopy)

Recruiting
  • Colonoscopy
  • +3 more
  • screening colonoscopy
  • Angers, France
  • +4 more
Dec 7, 2022

Lung Carcinoma, Metastatic Malignant Tumor in the Lung, Stage IV Lung Cancer AJCC v8 Trial in Palo Alto (procedure, drug, other)

Active, not recruiting
  • Lung Carcinoma
  • +4 more
  • Near-Infrared Fluorescence Imaging
  • +3 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jun 21, 2022

NSCLC Trial in Worldwide (Alectinib, Entrectinib, Pralsetinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • San José, Costa Rica
  • +3 more
Aug 4, 2022

Breast Cancer With Liposomal Doxorubicin Regimen

Recruiting
  • Breast Cancer
  • +4 more
  • Liposomal doxorubicin containing regimen
  • Hangzhou, Zhejiang, China
    Second Affiliate Hospital of Zhejiang University
Feb 7, 2023

Non-muscle Invasive Bladder Cancer (NMIBC), Bladder Tumor (TURBT) Trial in Cleveland (CBI)

Withdrawn
  • Non-muscle Invasive Bladder Cancer (NMIBC)
  • Bladder Tumor (TURBT)
  • CBI
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
May 10, 2022

Lymphoma, Lymphoma, Large B-Cell, Diffuse Trial in Boston (Glofitamab, Polatuzumab, Rituximab)

Not yet recruiting
  • Lymphoma
  • Lymphoma, Large B-Cell, Diffuse
  • Boston, Massachusetts
  • +1 more
Apr 4, 2023

NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +4 more
  • MK-2870
  • +2 more
  • (no location specified)
Sep 15, 2023

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,

Not yet recruiting
  • HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
  • PERT-IJS plus trastuzumab, carboplatin and docetaxel
  • Perjeta plus trastuzumab, carboplatin and docetaxel
  • (no location specified)
Sep 21, 2023

MONOCENTRIC PERSPECTIVE STUDY: USE OF LIQUID BIOPSY WITH

Recruiting
  • Breast Cancer
  • Liquid Biopsy
  • Liquid Biopsy
  • Naples, Italy
    University "Luigi Vanvitelli"
Nov 12, 2022

Chronic GVHD, Steroid Refractory GVHD Trial in Duarte (Leflunomide)

Recruiting
  • Chronic Graft Versus Host Disease
  • Steroid Refractory Graft Versus Host Disease
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus

Recruiting
  • Head and Neck Cancer
  • +6 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Shanghai, China
    Eye & ENT Hospital of Fudan University
Apr 13, 2023

Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle (Best

Not yet recruiting
  • Muscle Invasive Bladder Carcinoma
  • +2 more
  • Best Practice
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 18, 2023

Neck Syndrome Trial in Lahore (global postural reeducation, neck stabilization training)

Recruiting
  • Neck Syndrome
  • global postural reeducation
  • neck stabilization training
  • Lahore, Lahore,Punjab,Pakistan, Pakistan
    Sana Mubarak
Feb 20, 2022

Validating 'Sexual Minorities and Prostate Cancer Scale' to Gold

Not yet recruiting
  • Prostate Cancer
  • +2 more
    • (no location specified)
    Mar 6, 2023

    Prostate Carcinoma Trial in Guam, United States (Placebo Administration, Quality-of-Life Assessment, Questionnaire

    Recruiting
    • Prostate Carcinoma
    • Placebo Administration
    • +3 more
    • Phoenix, Arizona
    • +286 more
    Aug 10, 2022

    MRD Application in Colorectal Cancer Patients

    Recruiting
    • Colorectal Cancer
    • +2 more
      • Jinan, Shandong, China
        Jinan central hospital affiliated to Shandong First Medical Univ
      Sep 1, 2023

      Benign Kidney Tumor, Kidney Tumor, Renal Cell Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic

      Recruiting
      • Benign Kidney Neoplasm
      • +2 more
      • Hyperpolarized Carbon C 13 Pyruvate
      • +2 more
      • San Francisco, California
        University of California, San Francisco
      Jan 6, 2023

      Among Racially Diverse Zip Codes inPersistent Poverty County

      Not yet recruiting
      • Colorectal Cancer
      • Machine Learning Algorithm with Existing Penn Medicine CRC Patient Navigation Program
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Dec 6, 2022

      The '6 Minute Pegboard and Ring Test' in Breast Cancer

      Recruiting
      • Breast Cancer
      • +2 more
        • Ankara, State, Turkey
          Hacettepe University
        Aug 6, 2022

        Non-small Cell Lung Carcinoma, Urothelial Carcinoma, Gastrointestinal Carcinoma, Non-colon Trial in United States (afatinib,

        Completed
        • Non-small Cell Lung Carcinoma
        • +3 more
        • Denver, Colorado
        • +7 more
        Aug 17, 2022

        Deglutition Trial in Toulouse (Remote follow-up)

        Not yet recruiting
        • Deglutition
        • Remote follow-up
        • Toulouse, France
          CHU Toulouse
        Jan 6, 2023